333 related articles for article (PubMed ID: 32991235)
21. BCG Vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents.
Gong W; Mao Y; Li Y; Qi Y
Int Immunopharmacol; 2022 Jul; 108():108870. PubMed ID: 35597119
[TBL] [Abstract][Full Text] [Related]
22. Tuberculosis, BCG Vaccination, and COVID-19: Are They Connected?
Borges KCM; da Costa AC; de Souza Barbosa LC; Ribeiro KM; Dos Anjos LRB; Kipnis A; Junqueira-Kipnis AP
Mini Rev Med Chem; 2022; 22(12):1631-1647. PubMed ID: 34983348
[TBL] [Abstract][Full Text] [Related]
23. Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2.
Glisic S; Perovic VR; Sencanski M; Paessler S; Veljkovic V
J Proteome Res; 2020 Nov; 19(11):4649-4654. PubMed ID: 32794723
[TBL] [Abstract][Full Text] [Related]
24. Heterologous vaccine interventions: boosting immunity against future pandemics.
Marín-Hernández D; Nixon DF; Hupert N
Mol Med; 2021 May; 27(1):54. PubMed ID: 34058986
[TBL] [Abstract][Full Text] [Related]
25. Bacillus Calmette-Guerin Vaccine and Nonspecific Immunity.
Parmar K; Siddiqui A; Nugent K
Am J Med Sci; 2021 Jun; 361(6):683-689. PubMed ID: 33705721
[TBL] [Abstract][Full Text] [Related]
26. Sequence similarity of HSP65 of Mycobacterium bovis BCG with SARS-CoV-2 spike and nuclear proteins: may it predict an antigen-dependent immune protection of BCG against COVID-19?
Finotti P
Cell Stress Chaperones; 2022 Jan; 27(1):37-43. PubMed ID: 34755305
[TBL] [Abstract][Full Text] [Related]
27. BCG immunomodulation: From the 'hygiene hypothesis' to COVID-19.
Moulson AJ; Av-Gay Y
Immunobiology; 2021 Jan; 226(1):152052. PubMed ID: 33418320
[TBL] [Abstract][Full Text] [Related]
28. BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis.
Tomita Y; Sato R; Ikeda T; Sakagami T
Vaccine; 2020 Sep; 38(41):6352-6356. PubMed ID: 32863070
[TBL] [Abstract][Full Text] [Related]
29. Can BCG vaccine protect against COVID-19 via trained immunity and tolerogenesis?
Basak P; Sachdeva N; Dayal D
Bioessays; 2021 Mar; 43(3):e2000200. PubMed ID: 33169410
[TBL] [Abstract][Full Text] [Related]
30. Protection against SARS-CoV-2 by BCG vaccination is not supported by epidemiological analyses.
Hensel J; McAndrews KM; McGrail DJ; Dowlatshahi DP; LeBleu VS; Kalluri R
Sci Rep; 2020 Oct; 10(1):18377. PubMed ID: 33110184
[TBL] [Abstract][Full Text] [Related]
31. Cheap and Commonplace: Making the Case for BCG and γδ T Cells in COVID-19.
Morrison AL; Sharpe S; White AD; Bodman-Smith M
Front Immunol; 2021; 12():743924. PubMed ID: 34567010
[TBL] [Abstract][Full Text] [Related]
32. BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design.
Covián C; Fernández-Fierro A; Retamal-Díaz A; Díaz FE; Vasquez AE; Lay MK; Riedel CA; González PA; Bueno SM; Kalergis AM
Front Immunol; 2019; 10():2806. PubMed ID: 31849980
[TBL] [Abstract][Full Text] [Related]
33. Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and "New Old Friends".
Kleen TO; Galdon AA; MacDonald AS; Dalgleish AG
Front Immunol; 2020; 11():2059. PubMed ID: 33013871
[TBL] [Abstract][Full Text] [Related]
34. BCG activation of trained immunity is associated with induction of cross reactive COVID-19 antibodies in a BCG vaccinated population.
Iqbal NT; Ahmed K; Sattar T; Aziz F; Hussain R
PLoS One; 2024; 19(5):e0302722. PubMed ID: 38722827
[TBL] [Abstract][Full Text] [Related]
35. BCG Vaccination Program Mitigates COVID19 Related Mortality: A Reality Check.
Pandita A; Bhat A; Koul A; Singh SK
Curr Pharm Biotechnol; 2021; 22(12):1574-1583. PubMed ID: 33530904
[TBL] [Abstract][Full Text] [Related]
36. Natural and trained innate immunity against Mycobacterium tuberculosis.
Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
[TBL] [Abstract][Full Text] [Related]
37. Bacille Calmette Guérin (BCG) and new TB vaccines: Specific, cross-mycobacterial and off-target effects.
Fritschi N; Curtis N; Ritz N
Paediatr Respir Rev; 2020 Nov; 36():57-64. PubMed ID: 32958428
[TBL] [Abstract][Full Text] [Related]
38. Engineering a dual vaccine against COVID-19 and tuberculosis.
Guthrie CM; Tan X; Meeker AC; Self AE; Liu L; Cheng Y
Front Cell Infect Microbiol; 2023; 13():1273019. PubMed ID: 37965265
[TBL] [Abstract][Full Text] [Related]
39. A century of BCG: Impact on tuberculosis control and beyond.
Ahmed A; Rakshit S; Adiga V; Dias M; Dwarkanath P; D'Souza G; Vyakarnam A
Immunol Rev; 2021 May; 301(1):98-121. PubMed ID: 33955564
[TBL] [Abstract][Full Text] [Related]
40. BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers.
Rivas MN; Ebinger JE; Wu M; Sun N; Braun J; Sobhani K; Van Eyk JE; Cheng S; Arditi M
J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33211672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
